Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.

Fukui H.

J Clin Transl Hepatol. 2017 Sep 28;5(3):249-260. doi: 10.14218/JCTH.2017.00008. Epub 2017 Jun 29. Review.

2.

Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Fukui H.

World J Hepatol. 2015 Mar 27;7(3):425-42. doi: 10.4254/wjh.v7.i3.425. Review.

3.

Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver.

Lutz P, Nischalke HD, Strassburg CP, Spengler U.

World J Hepatol. 2015 Mar 27;7(3):304-14. doi: 10.4254/wjh.v7.i3.304. Review.

4.

Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?

de Mattos AA, Costabeber AM, Lionço LC, Tovo CV.

World J Gastroenterol. 2014 Oct 21;20(39):14079-86. doi: 10.3748/wjg.v20.i39.14079. Review.

5.

Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics.

Tuomisto S, Pessi T, Collin P, Vuento R, Aittoniemi J, Karhunen PJ.

BMC Gastroenterol. 2014 Feb 24;14:40. doi: 10.1186/1471-230X-14-40.

6.

Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis.

Tsung PC, Ryu SH, Cha IH, Cho HW, Kim JN, Kim YS, Moon JS.

Clin Mol Hepatol. 2013 Jun;19(2):131-9. doi: 10.3350/cmh.2013.19.2.131. Epub 2013 Jun 27.

7.

The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.

Seo YS, Shah VH.

Clin Mol Hepatol. 2012 Dec;18(4):337-46. doi: 10.3350/cmh.2012.18.4.337. Epub 2012 Dec 21. Review.

8.

The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease.

Hartmann P, Chen WC, Schnabl B.

Front Physiol. 2012 Oct 11;3:402. doi: 10.3389/fphys.2012.00402. eCollection 2012.

9.

Microbial translocation in chronic liver diseases.

Pinzone MR, Celesia BM, Di Rosa M, Cacopardo B, Nunnari G.

Int J Microbiol. 2012;2012:694629. doi: 10.1155/2012/694629. Epub 2012 Jul 17.

10.

Improving survival in decompensated cirrhosis.

Mukerji AN, Patel V, Jain A.

Int J Hepatol. 2012;2012:318627. doi: 10.1155/2012/318627. Epub 2012 Jul 2.

11.

Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial.

Kim SU, Chon YE, Lee CK, Park JY, Kim DY, Han KH, Chon CY, Kim S, Jung KS, Ahn SH.

Yonsei Med J. 2012 Mar;53(2):328-36. doi: 10.3349/ymj.2012.53.2.328.

12.

Antimicrobial prophylaxis in adults.

Enzler MJ, Berbari E, Osmon DR.

Mayo Clin Proc. 2011 Jul;86(7):686-701. doi: 10.4065/mcp.2011.0012. Review.

13.

Diagnosis and therapy of ascites in liver cirrhosis.

Biecker E.

World J Gastroenterol. 2011 Mar 14;17(10):1237-48. doi: 10.3748/wjg.v17.i10.1237.

14.

Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study.

Heo J, Seo YS, Yim HJ, Hahn T, Park SH, Ahn SH, Park JY, Park JY, Kim MY, Park SK, Cho M, Um SH, Han KH, Kim HS, Baik SK, Kim BI, Cho SH.

Gut Liver. 2009 Sep;3(3):197-204. doi: 10.5009/gnl.2009.3.3.197. Epub 2009 Sep 30.

15.

Spontaneous bacterial peritonitis.

Koulaouzidis A, Bhat S, Saeed AA.

World J Gastroenterol. 2009 Mar 7;15(9):1042-9. Review.

16.

Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis.

Loomba R, Wesley R, Bain A, Csako G, Pucino F.

Clin Gastroenterol Hepatol. 2009 Apr;7(4):487-493. doi: 10.1016/j.cgh.2008.12.018. Epub 2008 Dec 27.

17.

Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?

Ribeiro TC, Chebli JM, Kondo M, Gaburri PD, Chebli LA, Feldner AC.

Ther Clin Risk Manag. 2008 Oct;4(5):919-25.

18.

Spontaneous bacterial peritonitis.

Koulaouzidis A, Bhat S, Karagiannidis A, Tan WC, Linaker BD.

Postgrad Med J. 2007 Jun;83(980):379-83. Review.

19.

Gut flora and bacterial translocation in chronic liver disease.

Almeida J, Galhenage S, Yu J, Kurtovic J, Riordan SM.

World J Gastroenterol. 2006 Mar 14;12(10):1493-502. Review.

20.

Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites.

Genescà J, Martí R, Rojo F, Campos F, Peribáñez V, Gónzalez A, Castells L, Ruiz-Marcellán C, Margarit C, Esteban R, Guardia J, Segura R.

Gut. 2003 Jul;52(7):1054-9.

Supplemental Content

Support Center